Brooklyn Investment Group’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-17,209
Closed -$122K 1976
2025
Q4
$122K Buy
+17,209
New +$136K 0.01% 1449
2025
Q3
Sell
-4,165
Closed -$40.3K 2036
2025
Q2
$40.3K Buy
4,165
+1,095
+36% +$11.3K 0.01% 1460
2025
Q1
$45.7K Buy
3,070
+2,794
+1,012% +$43K 0.01% 822
2024
Q4
$4.11K Sell
276
-233
-46% -$3.8K ﹤0.01% 1280
2024
Q3
$9.74K Buy
+509
New +$10.6K ﹤0.01% 783

Other funds holding OGN

Brooklyn Investment Group's OGN Position: Q1 2026 in Review

Brooklyn Investment Group sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 17,209 shares — an estimated $122K sold.

Brooklyn Investment Group first reported a position in OGN in Q3 2024 and held it in 5 quarters. The position peaked at $122K in Q4 2025. 608 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Brooklyn Investment Group reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
  • Brooklyn Investment Group sold 17,209 Organon & Co shares in Q1 2026, an estimated $122K.
  • Brooklyn Investment Group first reported a position in Organon & Co in Q3 2024 and held it in 5 quarters.
  • Brooklyn Investment Group's Organon & Co position peaked at $122K in Q4 2025.
  • 608 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.